Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Posanski; Ulrich
Address:
Freiburg, DE
No. of patents:
19
Patents:












Patent Number Title Of Patent Date Issued
7511014 Cyclosporin galenic forms March 31, 2009
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
7235248 Pharmaceutical compositions comprising cyclosporins June 26, 2007
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2-Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weigh
7081445 Cyclosporin galenic forms July 25, 2006
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
6844459 Pharmaceutical Composition January 18, 2005
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri
6503883 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis January 7, 2003
The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p
6468968 Cyclosporin galenic forms October 22, 2002
Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10.
6262022 Pharmaceutical compositions containing cyclosporin as the active agent July 17, 2001
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri
6258808 Pharmaceutical composition July 10, 2001
Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-,di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterif
6204243 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis March 20, 2001
The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p
6024978 Pharmaceutical compositions comprising cyclosporins February 15, 2000
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular we
6007840 Pharmaceutical compositions comprising cyclosporins December 28, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5962017 Pharmaceutical compositions comprising cyclosporins October 5, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5962014 Pharmaceutical compositions comprising cyclosporins October 5, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5916589 Pharmaceutical compositions comprising cyclosporins June 29, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5866159 Pharmaceutical compositions comprising cyclosporins February 2, 1999
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5756450 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutic May 26, 1998
A combination of a pharmacologically active compound and a water soluble monoester of a saturated or unsaturated (C.sub.6-18) fatty acid and a polyol, especially a saccharide, particularly as a solid solution of the active compound in the monoester.The solid solution is especially suitab
5741512 Pharmaceutical compositions comprising cyclosporins April 21, 1998
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
5342625 Pharmaceutical compositions comprising cyclosporins August 30, 1994
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight
4567161 Liquid active ingredient concentrates for preparation of microemulsions January 28, 1986
Liquid, active substance formulations containing an active substance insoluble or poorly soluble in water, or a mixture, a phospholipid, a special co-emulsifier (glycerinester in which the 1 or 2 OH groups have been esterized with hydrocarbon atoms of 8-16, preferably 8-10, C atoms by










 
 
  Recently Added Patents
Method of enhancing corrosion resistance of hollow vessels
System and transceiver clocking to minimize required number of reference sources in multi-function cellular applications including GPS
All-angle light emitting element having high heat dissipating efficiency
Methods and system for providing drug pricing information from multiple pharmacy benefit managers (PBMs)
Display apparatus and control method thereof
Systems, devices, methods, and compositions including fluidized x-ray shielding compositions
Interest point detection
  Randomly Featured Patents
Waterproof toilet paper holder
Movable type x-ray photographing apparatus
Surrogate engine speed signal for controlling a dual clutch powershift transmission
Graded thickness optical element and method of manufacture therefor
Tokenless biometric transaction authorization system
Application of riluzole in the treatment of neurological lesions associated with trauma
Rechargeable miniature flashlight
Position detection system, medical-device guidance system, and position detection method
Process and installation for supplying caps to a closure machine
Polypeptides having acetylxylan esterase activity and polynucleotides encoding same